Sector Scan: Pharmaceutical Stocks

In the pharmaceutical sector, my scans have revealed four names to buy on strength and one stinker to avoid at all costs or sell if you own it. More 

Sector Scan: Healthcare Stocks

Find out which 3 healthcare stocks you should be buying, and which 3 to cut your losses on. More 

Sector Scan: Medical Stocks

This week medical stocks like Merck and Pfizer are looking healthy enough to buy or play calls on More 

Sector Scan: Medical Stocks

These medical stocks were in downward trends, but are rising temporarily before they hit resistance – which means opportunity for calls More 

Laying Out Our Strategy for the Second Half of 2012

The rest of the year will be driven in large part by four factors. See what they are -- and which five stocks are in a strong position to do well. More 

Earnings Season Brings Joy or Sorrow

Earnings season is difficult for everyone, as winners tend to get big stock bumps, while losers tend to go the other way: down. Hang on! More 

Here Comes a Bidding War for Amylin

Approval of its diabetes drug has Big Pharma banging on its door, with Bristol-Myers Squibb already said to have offered $3.5 billion, or $22 per share. More